Submit Deal

SOFINNOVA INVESTMENTS

Summary

Sofinnova Investments specializes in seed, startup, mid, early stage, series A, first venture round, and corporate spinouts.

Deals Overview

Total Deals10

Valued Deals9

Total Value£ 1.11 B

Avg. Deal Size£ 123 M

Market Context

Senior Management

Jim Healy
Managing Partner
James Healy
Managing Partner
Maha Katabi
General Partner

Sort

22 May 2023|United States|Biotechnology

Target: QUANTA THERAPEUTICS

Bidder: VIDA VENTURES

11 Service Providers

3 Target | 8 Bidder

11 Dealmakers

3 Target | 8 Bidder

£ 40 M

Value

27 Mar 2023|United States|Pharmaceuticals

Target: ARRIVENT BIOPHARMA

Bidder: SOFINNOVA INVESTMENTS

4 Service Providers

2 Target | 2 Bidder

3 Dealmakers

1 Target | 2 Bidder

£ 126 M

Value

05 Jun 2023|United States|Pharmaceuticals

Target: ALKEUS PHARMACEUTICALS

Bidder: BAIN CAPITAL LP

2 Service Providers

1 Target | 1 Bidder

3 Dealmakers

3 Target

£ 120 M

Value

24 Oct 2023|United States|Pharmaceuticals

Target: AIOLOS BIO INC

Bidder: RA CAPITAL MANAGEMENT

5 Service Providers

2 Target | 3 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 200 M

Value

23 Aug 2023|United States|Biotechnology

Target: RAPPORT THERAPEUTICS INC

Bidder: SOFINNOVA INVESTMENTS

5 Service Providers

2 Target | 3 Bidder

6 Dealmakers

3 Target | 3 Bidder

£ 117 M

Value

04 Jan 2024|United States|Pharmaceuticals

Target: ONCUSP THERAPEUTICS

Bidder: NOVO HOLDINGS A/S

5 Service Providers

1 Target | 4 Bidder

5 Dealmakers

1 Target | 4 Bidder

£ 78 M

Value

20 Mar 2024|United States|Biotechnology

Target: CAPSTAN THERAPEUTICS

Bidder: LEAPS BY BAYER

4 Service Providers

2 Target | 2 Bidder

4 Dealmakers

2 Target | 2 Bidder

£ 137 M

Value

26 Mar 2024|United States|Biotechnology

Target: AVENZO THERAPEUTICS

Bidder: DEEP TRACK CAPITAL

4 Service Providers

1 Target | 3 Bidder

5 Dealmakers

2 Target | 3 Bidder

n/a

Value

13 Feb 2024|United States|Biotechnology

Target: BIOAGE

Bidder: RTW INVESTMENTS

5 Service Providers

2 Target | 3 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 134 M

Value

18 Jun 2024|United States|Biotechnology

Target: MAREA THERAPEUTICS

Bidder: PERCEPTIVE XONTOGENY VENTURE FUND

5 Service Providers

2 Target | 3 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 149 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy